Cargando…

Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228

BACKGROUND: Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic en...

Descripción completa

Detalles Bibliográficos
Autores principales: Randhawa, Anmoldeep, Pasari, Nandita, Sinha, Tulika, Gupta, Mayank, Nair, Anju M., Ogunyewo, Olusola A., Verma, Sandhya, Verma, Praveen Kumar, Yazdani, Syed Shams
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836482/
https://www.ncbi.nlm.nih.gov/pubmed/33494787
http://dx.doi.org/10.1186/s13068-021-01883-4
_version_ 1783642758656819200
author Randhawa, Anmoldeep
Pasari, Nandita
Sinha, Tulika
Gupta, Mayank
Nair, Anju M.
Ogunyewo, Olusola A.
Verma, Sandhya
Verma, Praveen Kumar
Yazdani, Syed Shams
author_facet Randhawa, Anmoldeep
Pasari, Nandita
Sinha, Tulika
Gupta, Mayank
Nair, Anju M.
Ogunyewo, Olusola A.
Verma, Sandhya
Verma, Praveen Kumar
Yazdani, Syed Shams
author_sort Randhawa, Anmoldeep
collection PubMed
description BACKGROUND: Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic engineering tools. Tolerance towards common fungal antibiotics had been one of the major hindrances towards development of reliable transformation tools against the non-model fungi. In this study, we sought to understand the mechanism of drug tolerance of P. funiculosum and the provision to counter it. We then attempted to identify a robust method of transformation for genome engineering of this fungus. RESULTS: Penicillium funiculosum showed a high degree of drug tolerance towards hygromycin, zeocin and nourseothricin, thereby hindering their use as selectable markers to obtain recombinant transformants. Transcriptome analysis suggested a high level expression of efflux pumps belonging to ABC and MFS family, especially when complex carbon was used in growth media. Antibiotic selection medium was optimized using a combination of efflux pump inhibitors and suitable carbon source to prevent drug tolerability. Protoplast-mediated and Agrobacterium-mediated transformation were attempted for identifying efficiencies of linear and circular DNA in performing genetic manipulation. After finding Ti-plasmid-based Agrobacterium-mediated transformation more suitable for P. funiculosum, we improvised the system to achieve random and homologous recombination-based gene integration and deletion, respectively. We found single-copy random integration of the T-DNA cassette and could achieve 60% efficiency in homologous recombination-based gene deletions. A faster, plasmid-free, and protoplast-based CRISPR/Cas9 gene-editing system was also developed for P. funiculosum. To show its utility in P. funiculosum, we deleted the gene coding for the most abundant cellulase Cellobiohydrolase I (CBH1) using a pair of sgRNA directed towards both ends of cbh1 open reading frame. Functional analysis of ∆cbh1 strain revealed its essentiality for the cellulolytic trait of P. funiculosum secretome. CONCLUSIONS: In this study, we addressed drug tolerability of P. funiculosum and developed an optimized toolkit for its genome modification. Hence, we set the foundation for gene function analysis and further genetic improvements of P. funiculosum using both traditional and advanced methods.
format Online
Article
Text
id pubmed-7836482
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78364822021-01-26 Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228 Randhawa, Anmoldeep Pasari, Nandita Sinha, Tulika Gupta, Mayank Nair, Anju M. Ogunyewo, Olusola A. Verma, Sandhya Verma, Praveen Kumar Yazdani, Syed Shams Biotechnol Biofuels Research BACKGROUND: Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic engineering tools. Tolerance towards common fungal antibiotics had been one of the major hindrances towards development of reliable transformation tools against the non-model fungi. In this study, we sought to understand the mechanism of drug tolerance of P. funiculosum and the provision to counter it. We then attempted to identify a robust method of transformation for genome engineering of this fungus. RESULTS: Penicillium funiculosum showed a high degree of drug tolerance towards hygromycin, zeocin and nourseothricin, thereby hindering their use as selectable markers to obtain recombinant transformants. Transcriptome analysis suggested a high level expression of efflux pumps belonging to ABC and MFS family, especially when complex carbon was used in growth media. Antibiotic selection medium was optimized using a combination of efflux pump inhibitors and suitable carbon source to prevent drug tolerability. Protoplast-mediated and Agrobacterium-mediated transformation were attempted for identifying efficiencies of linear and circular DNA in performing genetic manipulation. After finding Ti-plasmid-based Agrobacterium-mediated transformation more suitable for P. funiculosum, we improvised the system to achieve random and homologous recombination-based gene integration and deletion, respectively. We found single-copy random integration of the T-DNA cassette and could achieve 60% efficiency in homologous recombination-based gene deletions. A faster, plasmid-free, and protoplast-based CRISPR/Cas9 gene-editing system was also developed for P. funiculosum. To show its utility in P. funiculosum, we deleted the gene coding for the most abundant cellulase Cellobiohydrolase I (CBH1) using a pair of sgRNA directed towards both ends of cbh1 open reading frame. Functional analysis of ∆cbh1 strain revealed its essentiality for the cellulolytic trait of P. funiculosum secretome. CONCLUSIONS: In this study, we addressed drug tolerability of P. funiculosum and developed an optimized toolkit for its genome modification. Hence, we set the foundation for gene function analysis and further genetic improvements of P. funiculosum using both traditional and advanced methods. BioMed Central 2021-01-25 /pmc/articles/PMC7836482/ /pubmed/33494787 http://dx.doi.org/10.1186/s13068-021-01883-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Randhawa, Anmoldeep
Pasari, Nandita
Sinha, Tulika
Gupta, Mayank
Nair, Anju M.
Ogunyewo, Olusola A.
Verma, Sandhya
Verma, Praveen Kumar
Yazdani, Syed Shams
Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title_full Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title_fullStr Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title_full_unstemmed Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title_short Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228
title_sort blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, penicillium funiculosum ncim1228
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836482/
https://www.ncbi.nlm.nih.gov/pubmed/33494787
http://dx.doi.org/10.1186/s13068-021-01883-4
work_keys_str_mv AT randhawaanmoldeep blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT pasarinandita blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT sinhatulika blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT guptamayank blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT nairanjum blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT ogunyewoolusolaa blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT vermasandhya blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT vermapraveenkumar blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228
AT yazdanisyedshams blockingdrugeffluxmechanismsfacilitategenomeengineeringprocessinhypercellulolyticfunguspenicilliumfuniculosumncim1228